246 related articles for article (PubMed ID: 8628315)
1. Functional regions of the mouse thrombopoietin receptor cytoplasmic domain: evidence for a critical region which is involved in differentiation and can be complemented by erythropoietin.
Porteu F; Rouyez MC; Cocault L; Bénit L; Charon M; Picard F; Gisselbrecht S; Souyri M; Dusanter-Fourt I
Mol Cell Biol; 1996 May; 16(5):2473-82. PubMed ID: 8628315
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of erythroid differentiation and induction of megakaryocytic differentiation by thrombopoietin are regulated by two different mechanisms in TPO-dependent UT-7/c-mpl and TF-1/c-mpl cell lines.
Goncalves F; Lacout C; Féger F; Cohen-Solal K; Guichard J; Cramer E; Vainchenker W; Duménil D
Leukemia; 1998 Sep; 12(9):1355-66. PubMed ID: 9737683
[TBL] [Abstract][Full Text] [Related]
3. Control of thrombopoietin-induced megakaryocytic differentiation by the mitogen-activated protein kinase pathway.
Rouyez MC; Boucheron C; Gisselbrecht S; Dusanter-Fourt I; Porteu F
Mol Cell Biol; 1997 Sep; 17(9):4991-5000. PubMed ID: 9271377
[TBL] [Abstract][Full Text] [Related]
4. Thrombopoietin activates a STAT5-like factor in hematopoietic cells.
Pallard C; Gouilleux F; Bénit L; Cocault L; Souyri M; Levy D; Groner B; Gisselbrecht S; Dusanter-Fourt I
EMBO J; 1995 Jun; 14(12):2847-56. PubMed ID: 7796811
[TBL] [Abstract][Full Text] [Related]
5. Establishment and characterization of the thrombopoietin-dependent megakaryocytic cell line, UT-7/TPO.
Komatsu N; Kunitama M; Yamada M; Hagiwara T; Kato T; Miyazaki H; Eguchi M; Yamamoto M; Miura Y
Blood; 1996 Jun; 87(11):4552-60. PubMed ID: 8639823
[TBL] [Abstract][Full Text] [Related]
6. Developmental expression of plasminogen activator inhibitor-1 associated with thrombopoietin-dependent megakaryocytic differentiation.
Madoiwa S; Komatsu N; Mimuro J; Kimura K; Matsuda M; Sakata Y
Blood; 1999 Jul; 94(2):475-82. PubMed ID: 10397715
[TBL] [Abstract][Full Text] [Related]
7. Identification of functional domains of the human thrombopoietin receptor required for growth and differentiation of megakaryocytic cells.
Takatoku M; Kametaka M; Shimizu R; Miura Y; Komatsu N
J Biol Chem; 1997 Mar; 272(11):7259-63. PubMed ID: 9054422
[TBL] [Abstract][Full Text] [Related]
8. Expression of the receptor MPL and proliferative effects of its ligand thrombopoietin on human leukemia cells.
Quentmeier H; Zaborski M; Graf G; Ludwig WD; Drexler HG
Leukemia; 1996 Feb; 10(2):297-310. PubMed ID: 8637239
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human c-Mpl ligand (thrombopoietin) not only acts on megakaryocyte progenitors, but also on erythroid and multipotential progenitors in vitro.
Tanimukai S; Kimura T; Sakabe H; Ohmizono Y; Kato T; Miyazaki H; Yamagishi H; Sonoda Y
Exp Hematol; 1997 Sep; 25(10):1025-33. PubMed ID: 9293899
[TBL] [Abstract][Full Text] [Related]
10. Dissecting the thrombopoietin receptor: functional elements of the Mpl cytoplasmic domain.
Drachman JG; Kaushansky K
Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2350-5. PubMed ID: 9122198
[TBL] [Abstract][Full Text] [Related]
11. Functional analysis of the cytoplasmic domain of the human Mpl receptor for tyrosine-phosphorylation of the signaling molecules, proliferation and differentiation.
Morita H; Tahara T; Matsumoto A; Kato T; Miyazaki H; Ohashi H
FEBS Lett; 1996 Oct; 395(2-3):228-34. PubMed ID: 8898102
[TBL] [Abstract][Full Text] [Related]
12. Thrombopoietin supports the continuous growth of cytokine-dependent human leukemia cell lines.
Drexler HG; Zaborski M; Quentmeier H
Leukemia; 1997 Apr; 11(4):541-51. PubMed ID: 9096695
[TBL] [Abstract][Full Text] [Related]
13. Protein kinase C mediates the mitogenic action of thrombopoietin in c-Mpl-expressing UT-7 cells.
Hong Y; Dumènil D; van der Loo B; Goncalves F; Vainchenker W; Erusalimsky JD
Blood; 1998 Feb; 91(3):813-22. PubMed ID: 9446641
[TBL] [Abstract][Full Text] [Related]
14. Involvement of prolonged ras activation in thrombopoietin-induced megakaryocytic differentiation of a human factor-dependent hematopoietic cell line.
Matsumura I; Nakajima K; Wakao H; Hattori S; Hashimoto K; Sugahara H; Kato T; Miyazaki H; Hirano T; Kanakura Y
Mol Cell Biol; 1998 Jul; 18(7):4282-90. PubMed ID: 9632812
[TBL] [Abstract][Full Text] [Related]
15. Thrombopoietin induces an SH2-containing protein, CIS1, which binds to Mpl: involvement of the ubiquitin proteosome pathway.
Okabe S; Tauchi T; Morita H; Ohashi H; Yoshimura A; Ohyashiki K
Exp Hematol; 1999 Oct; 27(10):1542-7. PubMed ID: 10517496
[TBL] [Abstract][Full Text] [Related]
16. Thrombopoietin-mediated sustained activation of extracellular signal-regulated kinase in UT7-Mpl cells requires both Ras-Raf-1- and Rap1-B-Raf-dependent pathways.
Garcia J; de Gunzburg J; Eychène A; Gisselbrecht S; Porteu F
Mol Cell Biol; 2001 Apr; 21(8):2659-70. PubMed ID: 11283246
[TBL] [Abstract][Full Text] [Related]
17. Tyrosine-599 of the c-Mpl receptor is required for Shc phosphorylation and the induction of cellular differentiation.
Alexander WS; Maurer AB; Novak U; Harrison-Smith M
EMBO J; 1996 Dec; 15(23):6531-40. PubMed ID: 8978680
[TBL] [Abstract][Full Text] [Related]
18. Thrombopoietin (c-mpl ligand) acts synergistically with erythropoietin, stem cell factor, and interleukin-11 to enhance murine megakaryocyte colony growth and increases megakaryocyte ploidy in vitro.
Broudy VC; Lin NL; Kaushansky K
Blood; 1995 Apr; 85(7):1719-26. PubMed ID: 7535585
[TBL] [Abstract][Full Text] [Related]
19. Role of the distal half of the c-Mpl intracellular domain in control of platelet production by thrombopoietin in vivo.
Luoh SM; Stefanich E; Solar G; Steinmetz H; Lipari T; Pestina TI; Jackson CW; de Sauvage FJ
Mol Cell Biol; 2000 Jan; 20(2):507-15. PubMed ID: 10611229
[TBL] [Abstract][Full Text] [Related]
20. A non-peptide compound which can mimic the effect of thrombopoietin via c-Mpl.
Kimura T; Kaburaki H; Tsujino T; Ikeda Y; Kato H; Watanabe Y
FEBS Lett; 1998 May; 428(3):250-4. PubMed ID: 9654143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
